Analysis of the Stability of 0.04% Mitomycin C Ophthalmic Solution under Various Storage Conditions

Yuma Nonomiya1,2, Koki Yamaguchi2, Yuta Yokoyama2

  • 1Department of Pharmacy, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.

PubMed

Insights

Hospital-prepared mitomycin C (MMC) ophthalmic solutions are unstable. Storing MMC solutions in the cold and shaded significantly enhances stability, determining its clinical use expiry date.

Area of Science:

  • Ophthalmology
  • Pharmaceutical Sciences
  • Chemical Stability

Background:

  • 0.04% mitomycin C (MMC) ophthalmic solution is prepared extemporaneously in hospitals.
  • Limited data exists on the physical properties and stability of this compounded ophthalmic preparation.

Purpose of the Study:

  • To evaluate the stability of hospital-prepared mitomycin C (MMC) ophthalmic solution.
  • To determine optimal storage conditions and establish an expiry date for clinical use.

Main Methods:

  • Mitomycin C (MMC) ophthalmic solution was prepared and stored under varied conditions: cold/shaded light, room temperature/shaded light, and room temperature/scattered light.
  • High-performance liquid chromatography (HPLC) was used to quantify MMC concentration over 21 days.
  • pH measurements and bacterial culture tests were performed.

Main Results:

  • MMC concentration decreased over time, with the most significant degradation occurring at room temperature with light exposure.
  • The lowest degradation rate was observed for solutions stored under cold conditions, protected from light.
  • pH increased from 5.8 to 6.9, and no bacterial contamination was detected.

Conclusions:

  • Mitomycin C (MMC) ophthalmic solution exhibits the greatest stability when stored under cold conditions and protected from light.
  • This study provides crucial data for establishing a reliable expiry date for clinical application of compounded MMC ophthalmic solutions.

Related Concept Videos

Drug Product Stability01:16

Drug Product Stability

The long-term stability of drug products is critical to ensuring their quality, safety, and effectiveness over time. Stability directly influences a product's ability to maintain its intended characteristics, ensuring it performs as expected during its intended shelf life. Key attributes such as drug potency, impurities, dissolution, and other physicochemical measures of performance are tested to assess stability. These parameters indicate how well the product retains its quality over time and...
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence01:22

Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence

Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
Ophthalmic Drug Delivery Systems01:23

Ophthalmic Drug Delivery Systems

Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...